HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Sulfisoxazole Acetyl

HCID 6662
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
80-74-0
Standard SMILES
CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1
InChIKey
JFNWFXVFBDDWCX-UHFFFAOYSA-N
Molecular formula
C13H15N3O4S
Average molar mass
309.34 g/mol
Monoisotopic mass
309.07832714

Overview

Sulfisoxazole acetyl is a member of benzenes and a sulfonamide.

Names & identifiers

Preferred name
Sulfisoxazole Acetyl
IUPAC
N-(4-aminophenyl)sulfonyl-N-(3,4-dimethyl-1,2-oxazol-5-yl)acetamide
English name
SULFISOXAZOLE ACETYL (200 MG)
Molecular formula
C13H15N3O4S
Molecular weight
309.3409

Names & synonyms

Sulfisoxazole acetyl80-74-0ACETYL SULFISOXAZOLELipo GantrisinacetylsulfafurazoleAcetylsulfisoxazoleGANTRISIN PEDIATRICAcetyl sulfafurazoleSulfafurazole acetylSulfisoxizole acetylWBT5QH3KEDNSC-759138
Show more names
ASIZN1-AcetylsulfisoxazoleSULFISOXAZOLE ACETYL (200 MG)Sulfisoxazole Acetyl (1639003)1-(oxazol-2-ylsulfinyl)ethanone
Sulfisoxazole acetyl (USP)Sulfisoxazole acetyl [USP]N-3,4-Dimethylisoxazol-5-yl-N-sulphanilylacetamideAcetamide, N-((4-aminophenyl)sulfonyl)-N-(3,4-dimethyl-5-isoxazolyl)-N-(4-aminobenzenesulfonyl)-N-(3,4-dimethyl-1,2-oxazol-5-yl)acetamideAcetamide, N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethyl-5-isoxazolyl)-RefChem:56070201-305-3

Database identifiers

CAS
80-74-0
PubChem CID
6662
DTXSID
DTXSID4023620
ChEMBL
CHEMBL1200910
ChEBI
CHEBI:135975
UNII
WBT5QH3KED

Properties

Computed structural properties

XLogP
1.3
Topological polar surface area
115 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
6
Rotatable bonds
3
Heavy atoms
21
Formal charge
0
Complexity
482

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section161.2 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
193 · 193-194°
Boiling point
538.1 · 538.1±60.0 °C(Predicted)
Density
1.3541 · 1.3541 (rough estimate)
refractive index
1.632 · 1.6320 (estimate)
pka
-0.17 · -0.17±0.10(Predicted)
form
Solid
color
White to off-white
Water Solubility
80 mg/L · 80mg/L(37 ºC)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
hs_code
2935904000
Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
11 - Combustible Solids
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Chemistry & industry

Pharmacology

Protein BindingApproximately 85% of a dose of sulfisoxazole is bound to plasma proteins, primarily to albumin; 65% to 72% of the unbound portion is in the nonacetylated form.
Pharmacodynamics · 1 item

Sulfisoxazole is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with action against most gram-positive and many gram-negative organisms. Many strains of an individual species may be resistant to this drugf. Sulfonamides inhibit the multiplication of bacteria by acting as competitive inhibitors of <i>p</i>-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.

Mechanism of Action · 1 item

Sulfisoxazole is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.

Biological Half-LifeThe serum half-life is 10 -12 hours.
Metabolism/Metabolites · 1 item

Sulfisoxazole acetyl is a prodrug of _sulfisoxazole_. The acetyl group is added to make the drug poorly water-soluble and is hydrolyzed in vivo to the active drug,. N1-acetyl sulfisoxazole is metabolized to sulfisoxazole by digestive enzymes in the gastrointestinal tract and is absorbed as sulfisoxazole. This enzymatic splitting is thought to be responsible for slower absorption and lower peak blood concentrations are achieved after administration of an equal oral dose of sulfisoxazole. With sustained administration of acetyl sulfisoxazole, blood concentrations approximate those of sulfisoxazole. Following a single 4 gram dose of acetyl sulfisoxazole to healthy volunteers, maximum plasma concentrations of sulfisoxazole ranged from 122 to 282 mcg/mL (mean, 181 mcg/mL) for the pediatric suspension and occurred between 2 and 6 hours postadministration of sulfisoxazole, in a pharmacokinetic study.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
EC Number
201-305-3
Nikkaji
J4.254D
Major Application
pharmaceutical (small molecule)
InChI
1S/C13H15N3O4S/c1-8-9(2)15-20-13(8)16(10(3)17)21(18,19)12-6-4-11(14)5-7-12/h4-7H,14H2,1-3H3
InChIKey
JFNWFXVFBDDWCX-UHFFFAOYSA-N
SMILES
[S](=O)(=O)(N(c2[o]nc(c2C)C)C(=O)C)c1ccc(cc1)N
FDA UNII
5 QH3KED · WBT5QH3KED
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501
WGK Germany
3 · WGK 3
HS Code
2935904000 · 2935904000
Storage Class
11 · 11 - Combustible Solids
Absorption, Distribution and Excretion · 4 items

Readily absorbed from the gastrointestinal tract. In a pharmacokinetic study, the adjustments for variable renal clearances between oral and intravenous administration and using the unbound plasma concentrations, the bioavailability for an oral dose of sulfisoxazole was found to be 0.95 +/- 0.04.

The mean urinary excretion recovery following oral administration of sulfisoxazole is 97% within 48 hours, of which 52% is the parent drug, and the remaining as the N4-acetylated metabolite. It is excreted in human milk. Sulfisoxazole and its acetylated metabolites are excreted primarily by the kidneys through glomerular filtration.

The sulfonamides are widely distributed throughout all body tissues. It readily crosses the placental barrier and enters into fetal circulation and also crosses the blood-brain barrier. In healthy subjects, cerebrospinal fluid concentrations of sulfisoxazole vary; in patients with meningitis, however, concentrations of free drug in cerebrospinal fluid as high as 94 mcg/mL have been reported. In a pharmacokinetic study, the apparent volume of distribution for total drug was 10.9 +/- 2.0 liters and 136 +/- 36 liters for the unbound drug, indicating that sulfisoxazole is primarily distributed extracellularly.

The clearance of sulfisoxazole is 18.7 +/- 3.9 ml/min for total drug and 232 +/- 64 ml/min for the unbound drug.

Applications · 3 items

UsesSulfisoxazole Acetyl is an antibiotic used in the prevention of infection especially when used in conjunction with erythromycin.

UsesAntibacterial.

General DescriptionSulfisoxazole acetyl shares the actions and usesof the parent compound, sulfisoxazole. The acetyl derivativeis tasteless and, therefore, suitable for oral administration, especiallyin liquid preparations. The acetyl compound is splitin the intestinal tract and absorbed as sulfisoxazole; that is, itis a prodrug for sulfisoxazole.

Upstream & downstream products

Upstream raw materials

AcetylsulfonamideIsoxazoleAnhydrous pyridineAcetic anhydrideSulfisoxazole

Additional notes

DefinitionChEBI: Sulfisoxazole acetyl is a sulfonamide and a member of benzenes.